Daxor Debt to Equity Ratio 2010-2011 | DXR
Current and historical debt to equity ratio values for Daxor (DXR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Daxor debt/equity for the three months ending December 31, 2011 was 0.00.
| Daxor Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2011-12-31 | $0.05B | $0.04B | 1.37 |
| 2011-09-30 | $0.05B | $0.04B | 1.35 |
| 2011-06-30 | $0.05B | $0.05B | 1.11 |
| 2011-03-31 | $0.05B | $0.05B | 1.01 |
| 2010-12-31 | $0.04B | $0.05B | 0.94 |
| 2010-09-30 | $0.04B | $0.05B | 0.79 |
| 2010-06-30 | $0.04B | $0.04B | 0.86 |
| 2010-03-31 | $0.04B | $0.05B | 0.87 |
| 2009-12-31 | $0.03B | $0.05B | 0.58 |
| 2009-09-30 | $0.03B | $0.05B | 0.58 |
| 2009-06-30 | $0.03B | $0.05B | 0.66 |
| 2009-03-31 | $0.03B | $0.03B | 0.95 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.047B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.509B | 9.99 |
| Quest Diagnostics (DGX) | United States | $15.276B | 15.79 |
| DaVita (DVA) | United States | $11.641B | 15.84 |
| Chemed (CHE) | United States | $9.342B | 29.00 |
| Encompass Health (EHC) | United States | $8.292B | 21.34 |
| Elanco Animal Health (ELAN) | United States | $6.576B | 14.95 |
| Option Care Health (OPCH) | United States | $5.202B | 19.69 |
| RadNet (RDNT) | United States | $3.333B | 97.34 |
| Amedisys (AMED) | United States | $2.974B | 21.08 |
| LifeStance Health (LFST) | United States | $2.358B | 0.00 |
| Astrana Health (ASTH) | United States | $2.051B | 25.88 |
| U.S Physical Therapy (USPH) | United States | $1.562B | 40.49 |
| Addus HomeCare (ADUS) | United States | $1.550B | 23.76 |
| Pennant (PNTG) | United States | $0.622B | 36.33 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.444B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.313B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.017B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| Ontrak (OTRK) | United States | $0.009B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |